Brian Jamieson

Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia

Wojciech Jurczak, Krzysztof Chojnowski, Katarzyna Krawczyk et al. · British Journal of Haematology · 2018 · 217 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)

Carlos M. Barrera, Analía Mykietiuk, Hristo Metev et al. · The Lancet Infectious Diseases · 2016 · 101 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia

David Oldach, Kay Clark, Jennifer Schranz et al. · Antimicrobial Agents and Chemotherapy · 2013 · 78 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +13

SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia

Thomas M. File, Barbara Rewerska, Violeta Vučinić-Mihailović et al. · Clinical Infectious Diseases · 2016 · 73 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea

Edward W. Hook, Matthew R. Golden, Brian Jamieson et al. · Clinical Infectious Diseases · 2015 · 62 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15